“…There are research results demonstrated that mangiferin possessed antidepressant and anti-anxiety properties due to its ability to attenuate IL-1β level and oxidative stress (including increasing reduced glutathione concentration and related enzyme activities) evoked by intraperitoneal administration of lipopolysaccharide [ 94 ]. Gu screened out Lilium lancifolium bulb saponins through untargeted and targeted metabolomics, found that it can not only effectively increase BDNF deposition but also modulates the glutamine and glutamate metabolism, restoring reduced glutamate levels in the brains of depressed rats; revealed the glutamatergic system was involved in the antidepressant activity of Lilium lancifolium bulb saponins (LS) [ 102 , 103 ]. Du used the CUMS rat depression model and found that Anemarrhena saponins (AS) could significantly restore monoamine neurotransmitter levels in the hippocampus of depressed rats, the metabonomic profile revealed the anti-depressant effect might be related to the regulation of several metabolic pathways, including amino acid, fatty acid, and phospholipid metabolism in rats, suggesting a synergetic effect of AS and LS in the treatment of depression [ 103 ].…”